Dr. Aaron Lee Boster, MD

Dr. Boster practices at Levey Innovative Therapeutics in Columbus, Ohio.

Dr. Boster's NPI, 1760641740, was assigned on June 5, 2008. Dr. Boster graduated from University Of Cincinnati College Of Medicine in 2002. Dr. Boster holds Ohio license 35091626.

Dr. Boster's primary practice is Levey Innovative Therapeutics, at 8000 Ravines Edge Ct Suite 200 Suite 200, Columbus, OH 43235-5422. The practice phone is (614) 304-3444.

Dr. Boster's primary practice is Levey Innovative Therapeutics in Columbus, Ohio. Dr. Boster is also affiliated with OhioHealth Marion General Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Boster to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boster practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Boster's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Boster is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Boster's licenses on file in 11 states: Ohio, Tennessee, Illinois, Kentucky, Michigan, Washington, West Virginia, Alabama, Indiana, Texas and Wisconsin.

Dmand AI lists fibromyalgia and chronic pain, mobility impairment and multiple sclerosis among the conditions Dr. Boster treats.

CMS data shows 27,524 Medicare services from Dr. Boster across 11 procedure codes in 2024, for 98 Medicare patients. Medicare paid $946,551 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Dr. Boster in 2024. The largest group is under 65, with 48 patients. 56% of them have high cholesterol, and 50% have mood disorders. 20% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boster's median patient age at 50, with 74% women.

In 2024, Dr. Boster wrote 2,142 Medicare Part D claims for 169 patients. 90% of them were for generic drugs. CMS names the drug for 1,803 of them, across 46 drugs with 11 or more claims each, at $920,548 in total drug cost. In 2023, CMS named 1,648 claims across 45 drugs.

Dr. Boster accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boster as offering telehealth.

Dmand AI links 46 papers to Dr. Boster, published from 2012 to 2021. 2013 was the busiest year, with 5. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Multiple Sclerosis, Relapsing-Remitting. Dr. Boster has published most often in Neuromodulation. Dr. Boster's most frequent co-authors are Michael Karl Racke, MD, Ann Doan Bass, MD and Barry A. Singer.

Dmand AI links Dr. Boster to 14 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Demyelinating Autoimmune Diseases, CNS. Genzyme, a Sanofi Company sponsors the most, 4. Open Payments lists research payments to Dr. Boster that name 5 trials.

CMS Open Payments shows 2,153 general payments to Dr. Boster from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Sanofi and Genzyme US Companies paid the most, $918,243. It also lists 166 research payments totaling $83,506 from 2016 to 2022, naming 5 clinical trials.

Dmand AI lists 1 award for Dr. Boster, most recently CMS Stage 1 EHR in 2013.

Dr. Boster graduated from University Of Cincinnati College Of Medicine in 2002.

Dr. Boster is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.